BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gunnarsson R, Hetlevik SO, Lilleby V, Molberg Ø. Mixed connective tissue disease. Best Practice & Research Clinical Rheumatology 2016;30:95-111. [DOI: 10.1016/j.berh.2016.03.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
Number Citing Articles
1 Murakami K, Mimori T. Recent Advances in Research Regarding Autoantibodies in Connective Tissue Diseases and Related Disorders. Intern Med 2019;58:5-14. [PMID: 30146596 DOI: 10.2169/internalmedicine.1423-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
2 Barturen G, Alarcón-Riquelme ME. SLE redefined on the basis of molecular pathways. Best Pract Res Clin Rheumatol 2017;31:291-305. [PMID: 29224672 DOI: 10.1016/j.berh.2017.09.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
3 Yang CF, Chiu JY, Su CW, Chen CM. Chondral grafts for condylar reconstruction in treatment of temporomandibular joint arthritis in a mixed connective tissue disease patient. Kaohsiung J Med Sci 2019;35:787-8. [PMID: 31512336 DOI: 10.1002/kjm2.12128] [Reference Citation Analysis]
4 Reiseter S, Gunnarsson R, Corander J, Haydon J, Lund MB, Aaløkken TM, Taraldsrud E, Hetlevik SO, Molberg Ø. Disease evolution in mixed connective tissue disease: results from a long-term nationwide prospective cohort study. Arthritis Res Ther 2017;19:284. [PMID: 29268795 DOI: 10.1186/s13075-017-1494-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
5 Yamakawa H, Hagiwara E, Kitamura H, Yamanaka Y, Ikeda S, Sekine A, Baba T, Okudela K, Iwasawa T, Takemura T, Kuwano K, Ogura T. Serum KL-6 and surfactant protein-D as monitoring and predictive markers of interstitial lung disease in patients with systemic sclerosis and mixed connective tissue disease. J Thorac Dis 2017;9:362-71. [PMID: 28275485 DOI: 10.21037/jtd.2017.02.48] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
6 Jackson N, Betty S, Appiah-Pippim J, Bueno Y, Makhdumi S. The dilemma: scleroderma renal crisis vs lupus nephritis in a patient with mixed connective tissue disorder. J Community Hosp Intern Med Perspect 2021;11:852-5. [PMID: 34804405 DOI: 10.1080/20009666.2021.1983320] [Reference Citation Analysis]
7 Tešija Kuna A, Đerek L, Drvar V, Kozmar A, Gugo K. Assessment of antinuclear antibodies (ANA): National recommendations on behalf of the Croatian society of medical biochemistry and laboratory medicine. Biochem Med (Zagreb) 2021;31:020502. [PMID: 33927550 DOI: 10.11613/BM.2021.020502] [Reference Citation Analysis]
8 Garen T, Lerang K, Hoffmann-vold A, Andersson H, Midtvedt Ø, Brunborg C, Kilian K, Gudbrandsson B, Gunnarsson R, Norby G, Chaudhary A, Thoen J, Forseth KØ, Fresjar K, Førre Ø, Haugen M, Haga H, Gran JT, Gilboe I, Molberg Ø, Palm Ø. Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides. Rheumatology 2019;58:313-20. [DOI: 10.1093/rheumatology/key285] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
9 Yilmaz OK, Haeberle S, Zhang M, Fritzler MJ, Enk AH, Hadaschik EN. Scurfy Mice Develop Features of Connective Tissue Disease Overlap Syndrome and Mixed Connective Tissue Disease in the Absence of Regulatory T Cells. Front Immunol 2019;10:881. [PMID: 31068947 DOI: 10.3389/fimmu.2019.00881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Oka S, Higuchi T, Furukawa H, Shimada K, Hashimoto A, Komiya A, Matsui T, Fukui N, Suematsu E, Ohno S, Kono H, Katayama M, Nagaoka S, Migita K, Tohma S. Predisposition of HLA-DRB1*04:01/*15 heterozygous genotypes to Japanese mixed connective tissue disease. Sci Rep 2022;12:9916. [PMID: 35705662 DOI: 10.1038/s41598-022-14116-x] [Reference Citation Analysis]
11 Kondoh Y, Makino S, Ogura T, Suda T, Tomioka H, Amano H, Anraku M, Enomoto N, Fujii T, Fujisawa T, Gono T, Harigai M, Ichiyasu H, Inoue Y, Johkoh T, Kameda H, Kataoka K, Katsumata Y, Kawaguchi Y, Kawakami A, Kitamura H, Kitamura N, Koga T, Kurasawa K, Nakamura Y, Nakashima R, Nishioka Y, Nishiyama O, Okamoto M, Sakai F, Sakamoto S, Sato S, Shimizu T, Takayanagi N, Takei R, Takemura T, Takeuchi T, Toyoda Y, Yamada H, Yamakawa H, Yamano Y, Yamasaki Y, Kuwana M; joint committee of Japanese Respiratory Society and Japan College of Rheumatology. 2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease. Respir Investig 2021;59:709-40. [PMID: 34602377 DOI: 10.1016/j.resinv.2021.04.011] [Reference Citation Analysis]
12 Inoue Y, Ogura T, Yamashita N, Takenaka S, Ito H, Hirata A, Katagiri T, Takakura Y, Imaizumi C, Mizushina K, Imamura M, Kujime R, Hayashi N, Kameda H. Performance of the Revised Classification Criteria for Systemic Autoimmune Rheumatic Diseases and Their Overlap Syndromes. Intern Med 2022;61:1947-52. [PMID: 35781270 DOI: 10.2169/internalmedicine.8487-21] [Reference Citation Analysis]
13 Norimatsu Y, Yoshizaki A, Kabeya Y, Fukasawa T, Omatsu J, Fukayama M, Kuzumi A, Ebata S, Yoshizaki-Ogawa A, Asano Y, Ichimura H, Yonezawa S, Nakano H, Sato S. Expert-Level Distinction of Systemic Sclerosis from Hand Photographs Using Deep Convolutional Neural Networks. J Invest Dermatol 2021;141:2536-9. [PMID: 33836180 DOI: 10.1016/j.jid.2021.03.020] [Reference Citation Analysis]
14 Perelas A, Arrossi AV, Highland KB. Pulmonary Manifestations of Systemic Sclerosis and Mixed Connective Tissue Disease. Clin Chest Med 2019;40:501-18. [PMID: 31376887 DOI: 10.1016/j.ccm.2019.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Pisetsky DS. Antinuclear antibody testing — misunderstood or misbegotten? Nat Rev Rheumatol 2017;13:495-502. [DOI: 10.1038/nrrheum.2017.74] [Cited by in Crossref: 74] [Cited by in F6Publishing: 60] [Article Influence: 14.8] [Reference Citation Analysis]
16 Gameiro RS, Reis AIA, Grilo AC, Noronha C. Following leads: connecting dysphagia to mixed connective tissue disease. BMJ Case Rep 2018;2018:bcr-2017-223699. [PMID: 29507032 DOI: 10.1136/bcr-2017-223699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Wang CR, Tsai HW. Autoimmune liver diseases in systemic rheumatic diseases. World J Gastroenterol 2022; 28(23): 2527-2545 [DOI: 10.3748/wjg.v28.i23.2527] [Reference Citation Analysis]
18 Hao Y, Feng L, Teng Y, Cheng Y, Feng J. Management of multiple neurological complications in mixed connective tissue disease: A case report. Medicine (Baltimore) 2018;97:e11360. [PMID: 30075502 DOI: 10.1097/MD.0000000000011360] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Wanzenried A, Garaiman A, Jordan S, Distler O, Maurer B. The enigma of mixed connective tissue disease-challenges in routine care. Clin Rheumatol 2022. [PMID: 35902486 DOI: 10.1007/s10067-022-06286-w] [Reference Citation Analysis]
20 Chin D, Gan NY, Holder GE, Tien M, Agrawal R, Manghani M. Severe retinal vasculitis in systemic lupus erythematosus leading to vision threatening paracentral acute middle maculopathy. Mod Rheumatol Case Rep 2021;5:265-71. [PMID: 33627049 DOI: 10.1080/24725625.2021.1893961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Lhote R, Grenier P, Haroche J, Miyara M, Boussouar S, Mathian A, Pha M, Amoura Z, Cohen Aubart F. Characterization of Interstitial Lung Disease Associated With Anti-Ribonucleoprotein Antibodies. J Clin Rheumatol 2020;26:327-33. [PMID: 31415476 DOI: 10.1097/RHU.0000000000001127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
22 Jee AS, Sheehy R, Hopkins P, Corte TJ, Grainge C, Troy LK, Symons K, Spencer LM, Reynolds PN, Chapman S, de Boer S, Reddy T, Holland AE, Chambers DC, Glaspole IN, Jo HE, Bleasel JF, Wrobel JP, Dowman L, Parker MJS, Wilsher ML, Goh NSL, Moodley Y, Keir GJ. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand. Respirology 2021;26:23-51. [PMID: 33233015 DOI: 10.1111/resp.13977] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Liu Z, Yang X, Tian Z, Qian J, Wang Q, Zhao J, Huang C, Liu Y, Guo X, Wang H, Lai J, Li M, Zhao Y, Zeng X. The prognosis of pulmonary arterial hypertension associated with primary Sjögren's syndrome: a cohort study. Lupus 2018;27:1072-80. [PMID: 29419347 DOI: 10.1177/0961203318756287] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
24 Liang R, Landry I, Saliaj M. Systemic Lupus Erythematosus vs. Mixed Connective Tissue Disease Disguised As Scabies. Cureus. [DOI: 10.7759/cureus.23621] [Reference Citation Analysis]
25 Tanaka Y, Kuwana M, Fujii T, Kameda H, Muro Y, Fujio K, Itoh Y, Yasuoka H, Fukaya S, Ashihara K, Hirano D, Ohmura K, Tabuchi Y, Hasegawa H, Matsumiya R, Shirai Y, Ogura T, Tsuchida Y, Ogawa-Momohara M, Narazaki H, Inoue Y, Miyagawa I, Nakano K, Hirata S, Mori M. 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): From the Japan research committee of the ministry of health, labor, and welfare for systemic autoimmune diseases. Mod Rheumatol 2021;31:29-33. [PMID: 31903831 DOI: 10.1080/14397595.2019.1709944] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Casanegra AI, Shepherd RF. Raynaud Phenomenon and Other Vasospastic Disorders. Cardiol Clin 2021;39:583-99. [PMID: 34686269 DOI: 10.1016/j.ccl.2021.06.010] [Reference Citation Analysis]
27 Lepreux S, Hainfellner JA, Vital A. Idiopathic inflammatory myopathies overlapping with systemic diseases. Clin Neuropathol 2018;37:6-15. [PMID: 29154752 DOI: 10.5414/NP301077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
28 Missounga L, Ba JI, Nseng Nseng Ondo IR, Nziengui Madjinou MIC, Malekou D, Mouendou Mouloungui EG, Nzengue EE, Boguikouma JB, Kombila M. [Mixed connective tissue disease: prevalence and clinical characteristics in African black, study of 7 cases in Gabon and review of the literature]. Pan Afr Med J 2017;27:162. [PMID: 28904690 DOI: 10.11604/pamj.2017.27.162.12572] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Shenavandeh S, Habibi S, Habibi Y, Nazarinia M. Mechanic hands: clinical and capillaroscopy manifestations of patients with connective tissue diseases presented with and without mechanic hands. Clin Rheumatol 2019;38:2309-18. [DOI: 10.1007/s10067-018-04422-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
30 Stypinska B, Wajda A, Walczuk E, Olesinska M, Lewandowska A, Walczyk M, Paradowska-Gorycka A. The Serum Cell-Free microRNA Expression Profile in MCTD, SLE, SSc, and RA Patients. J Clin Med 2020;9:E161. [PMID: 31936082 DOI: 10.3390/jcm9010161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
31 Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int 2018;38:1169-78. [DOI: 10.1007/s00296-018-4059-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
32 Vahdatpour CA, Darnell ML, Palevsky HI. Acute Respiratory Failure in Interstitial Lung Disease Complicated by Pulmonary Hypertension. Respir Med 2020;161:105825. [PMID: 31785507 DOI: 10.1016/j.rmed.2019.105825] [Reference Citation Analysis]
33 Paravar T. Less common rheumatologic disorders: Current concepts of skin and systemic manifestations. Clinics in Dermatology 2018;36:525-32. [DOI: 10.1016/j.clindermatol.2018.04.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
34 Valentini G, Pope JE. Undifferentiated connective tissue disease at risk for systemic sclerosis: Which patients might be labeled prescleroderma? Autoimmun Rev 2020;19:102659. [PMID: 32942034 DOI: 10.1016/j.autrev.2020.102659] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Kang EH, Song YW. Pharmacological Interventions for Pulmonary Involvement in Rheumatic Diseases. Pharmaceuticals (Basel) 2021;14:251. [PMID: 33802193 DOI: 10.3390/ph14030251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Palmucci S, Galioto F, Fazio G, Ferlito A, Cancemi G, Di Mari A, Sambataro G, Sambataro D, Zanframundo G, Mauro LA, Foti PV, Vancheri C, Basile A. Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial essay. Insights Imaging 2022;13:108. [PMID: 35767157 DOI: 10.1186/s13244-022-01243-2] [Reference Citation Analysis]
37 Nishioka R, Zoshima T, Hara S, Suzuki Y, Ito K, Yamada K, Nakashima A, Tani Y, Kawane T, Hirata M, Mizushima I, Kawano M. Urinary abnormality in mixed connective tissue disease predicts development of other connective tissue diseases and decrease in renal function. Mod Rheumatol 2021;:1-8. [PMID: 33706652 DOI: 10.1080/14397595.2021.1899602] [Reference Citation Analysis]
38 Sköldstam J, Alsén B, Dahlin C. Mixed connective tissue disease with temporomandibular joint ankylosis: A case report. Oral and Maxillofacial Surgery Cases 2019;5:100109. [DOI: 10.1016/j.omsc.2019.100109] [Reference Citation Analysis]
39 Celińska-Löwenhoff M, Pastuszczak M, Pełka K, Stec-Polak M, Wojas-Pelc A, Musiał J. Associations between nailfold capillaroscopy findings and interstitial lung disease in patients with mixed connective tissue disease. Arch Med Sci 2020;16:297-301. [PMID: 32190139 DOI: 10.5114/aoms.2018.81129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]